Skip to main content

Cystic liver lesions: a pictorial review


Hepatic cysts (HC) are sac-like structures mainly filled with liquid and showing a distinct membrane. They are usually found incidentally through imaging. A wide spectrum of imaging patterns may be observed for common and uncommon, neoplastic and non-neoplastic diseases. While simple hepatic cysts occur frequently and do not require any treatment or follow-up, non-typical cysts should be carefully analysed to avoid misdiagnosing a lesion that would require appropriate management. Therefore, adequate knowledge of all the relevant imaging patterns is critical to secure an accurate diagnosis. The aim of this review is to describe the imaging features of the different types of hepatic cysts.

Key points

  • Cystic liver lesions are common lesions dominated by simple hepatic cysts.

  • Aetiologies of hepatic cysts are varied: developmental, infectious, neoplastic.

  • Atypical characteristics of hepatic cysts should always be searched for.

  • Atypical features are: thick wall, septa or solid portion, enhancement, non-fluid signal.

  • The clinical context must always be considered.


Hepatic cysts are frequent (2.5% to 18% in the general population), mostly incidental and asymptomatic lesions [1,2,3]. They are well-defined fluid-filled lesions, with or without epithelial lining. Depending on the lesion, the cystic component may be composed of different types of fluid, including bilious, serous, mucinous, necrotic, haemorrhagic, proteinaceous or mixed fluid [4, 5]. Some of them may be diagnosed non-invasively on the basis of specific imaging features [5]. Radiologists should both know and recognise non-typical benign features—i.e. wall thickness, presence of septa, tissular component, enhancement, and signal intensity on MRI [7, 9]—and systematically take the clinical context into consideration.

The aim of this article is to describe and illustrate some of the most frequent cystic hepatic lesions, with a special emphasis on typical radiological features, which allow a non-invasive diagnosis. Even though the extra-hepatic bile ducts abnormalities, rare tumours sometimes cystic (hepatocellular carcinoma, mucinous cholangiocarcinoma, etc.) and post-traumatic lesions will not be addressed in this review, they are listed in Table 1.

Table 1 Other cystic lesions that could be evocated as differential diagnosis

A summary of the imaging patterns for each cystic disease is presented in Table 2. Finally, Fig. 1 shows a diagnostic algorithm.

Table 2 Summary of the imaging patterns for each cystic disease
Fig. 1
figure 1

Simple algorithms helping to delineate diagnosis according to the number of cysts

Ductal abnormalities

Ductal plate malformations correspond to a group of congenital cystic liver lesions, which can affect both the intra- and/or the extrahepatic biliary ducts. They result from insufficient remodelling and resorption of cylindrical ductal plates [8]. Figure 2 emphasises the stage of ductal plate malformation according to the development of the bile duct, from the centre to the periphery.

Fig. 2
figure 2

Schematic figure (axial section of a liver) showing the different types of ductal plate malformation. The size of the affected ducts is closely correlated to the ductal development phase

Simple hepatic cyst


Simple hepatic cysts (SHC) (also known as bile duct cysts or biliary cysts) are congenital parts of the ductal tree detached from the main biliary system, which dilated to become cystic lesion [9]. There is no consensus on their actual origin. They are thought by some authors to result from the dilatation of the bile duct hamartoma (cf. section) [4], and they do not communicate with the biliary tract. In the literature, their prevalence is reported to range from 2.5 to 18%, occurring more frequently in women, with an incidence that increases with age [5, 10, 11].

SHCs are benign lesions, which are usually asymptomatic. Cystic serous fluid is continually produced by the cuboidal biliary epithelium [10]. A very large cyst can cause abdominal pain or early satiety by compression. Complications, which may include haemorrhage or infection, are rare and may result in the lesion becoming a “complex cyst”.


A SHC is a well-circumscribed unilocular lesion with a thin imperceptible wall, which may be lobulated; it is anechoic on ultrasonography (US) with increased through-transmission. A SHC is hypoattenuating on computed tomography (CT) images (0–20 HU) and appears as hypointense on T1 and strongly hyperintense on T2 images with magnetic resonance imaging (MRI). It does not have internal nodule and does not show enhancement after the administration of intra-venous contrast agents (whether with US, CT or MRI) (Figs. 3 and 4). It can be bi- or multi-lobar (fused cysts) (Fig. 6). The typical features on each imaging modality are sufficient findings allowing a confident diagnosis.

Fig. 3
figure 3

Incidentally found simple hepatic cyst in an asymptomatic 64-year-old male. a Ultrasonography shows a round homogeneous anechoic cystic hepatic lesion, well-circumscribed and without any mural nodule or vegetation. The arrows show an increased through transmission, confirming the cystic nature of the lesion. b T2-weighted magnetic resonance imaging shows a highly hyperintense round lesion. c and d Computed tomography without and with contrast on portal venous phase shows a round homogeneous non-enhancing hypoattenuating lesion (3 Hounsfield Units)

Fig. 4
figure 4

Very large simple hepatic cyst in a symptomatic 64-year-old female with abdominal pain. a Axial and (b) coronal computed tomography on portal venous phase shows a very large simple hepatic cyst. The cyst had grown progressively for a certain number of years and was eventually treated by laparoscopic fenestration, resulting in pain relief

“Complex cyst”

Complications of SHCs are rare. However, they need to be recognised, since they change the features of the cyst and could therefore lead to misdiagnosis. This is especially the case of tumoural cysts [11].

  • Haemorrhage: these cysts can increase in size. They have a heterogeneous content with septations seen as echoic intralesional materials (Fig. 5) (pain can occur during ultrasound examination). On CT, their attenuation is higher than that of simple fluid and, on MRI, the signal produced is that generated by blood flow according to the stage of the bleeding (Figs. 6 and 7). A fluid–fluid level can be observed (Fig. 6). The inner septa are mobile but do not enhance. A pseudo-capsule in the form of a thin peripheral rim enhancement is depicted and should not be mistaken for tumoural tissue.

  • Infections: they are exceptional, except in the case of polycystic disease. A thick wall with heterogeneous enhancement, a fluid–fluid level and some gas bubbles inside the cyst can be seen. It can be difficult to differentiate these cysts from abscesses, unless a prior examination demonstrated the presence of SHCs.

  • Rupture: rupture also occurs very rarely and a typical sign suggesting rupture is a “floating wall” inside the cyst. In case of a subcapsular cyst, a rupture can be associated with perihepatic fluid (Fig. 8).

  • Large symptomatic SHC: even though very large SHCs are usually asymptomatic, they could cause pain or duodenogastric compression. The treatment may be surgical (cyst fenestration) or radiological by sclerotherapy. Due to the difficulty in attributing symptoms to the cyst, a diagnostic test can be carried out through a simple aspiration.

Fig. 5
figure 5

Subacute haemorrhage in a simple hepatic cyst in a 70-year-old male. Ultrasonography shows a spontaneous mobile area of hyperechogenicity inside the cyst, appearing as a “fern leaf”

Fig. 6
figure 6

Bilobulated haemorrhagic hepatic cyst in a 73-year-old female. a Coronal non-enhanced computed tomography shows a bilobulated cyst with focal hyperattenuation in the inferior part (arrow); b coronal T2-weighted magnetic resonance imaging shows heterogeneous hypointensity inside the inferior part of the cyst (arrow). c Contrast-enhanced ultrasonography confirms the non-enhancement of the cystic part of the lesion (arrowhead)

Fig. 7
figure 7

Haemorrhagic cyst in a 55-year-old male patient. a Axial T1 fat-sat-weighted magnetic resonance imaging shows hyperintense lesion and (b) axial T2-weighted magnetic resonance imaging shows a heterogeneous hyperintensity; c and d axial T1-fat-sat-weighted imaging without and with subtraction shows no enhancement after gadolinium-chelate injection

Fig. 8
figure 8

Rupture of a hepatic cyst in a 89-year-old male with severe abdominal pain. Axial computed tomography on portal venous phase demonstrates a floating wall (arrow) associated with pericystic and peri-hepatic fluid collection

Bile duct hamartoma


Bile duct hamartomas (BH) (also known as von Meyenburg complexes) are benign lesions caused by failure of the small interlobular bile ducts to involute at the late phase of embryogenesis [1214]. BHs are asymptomatic and disconnected bile duct lesions with only limited dilation, lined by biliary epithelium. The prevalence based on autopsy series is around 5.6% in adults [13]. BHs can be observed in healthy livers or in association with other ductal plate abnormalities [13]. As of 2016, 35 cases of cholangiocarcinoma associated with BH have been reported in the literature, without other associated ductal plate malformation [13].


BHs are commonly subcapsular or located at the periphery of portal tracts [12]. US images show multiple small (< 1.5 cm) intra-hepatic cysts, which are mostly hyperechoic due to their small size and to a fibrous stroma (Fig. 9a), with comet-tail artefacts [4, 13]. The pattern they produce has been described as a “snowstorm” [14]. They are poorly visible on CT, round or irregular in shape, with strict fluid attenuation and no enhancement (Fig. 9c). MRI allows a better detection with a strongly T2-weighted sequence [13] resulting in a “starry sky” appearance [15] (Fig. 9d). Magnetic resonance cholangiopancreatography (MRCP) sequences confirm the lack of communication with the biliary tract (Fig. 9b). In some cases, a thin regular persistent enhanced rim can be seen due to the compressed surrounding liver parenchyma [4]. The typical features on each imaging modality are sufficient to reach a conclusive diagnosis. It may be difficult to discriminate between bile duct hamartomas and simple hepatic cysts when there are only few bile duct hamartomas in the liver parenchyma. The main differentiating patterns include the size of the lesion (small) and their disposition (mostly peripheral). However, from a clinical standpoint, setting them apart is not critical, because both are benign lesions.

Fig. 9
figure 9

Bile duct hamartomas in a 52-year-old female. a Multiple hyperechoic round nodules (arrows) at ultrasonography, displaying a “snowstorm” pattern. b Coronal magnetic resonance cholangiopancreatography shows several small hyperintense nodules, which do not communicate with the biliary tract (arrows). c Axial computed tomography on portal venous phase shows bilobar small round-shaped hypoattenuating nodules, which can be better detected with an axial magnetic resonance cholangiopancreatography sequence (d)

Caroli syndrome and disease

These are both extremely rare congenital ductal plate development abnormalities (prevalence of less than one in 1,000,000 inhabitants) [16]. Caroli disease (CD) occurs less frequently than Caroli syndrome (CS). CS must be differentiated from CD. Their pathophysiology is different. CD results from the abnormal development of large bile ducts, whereas CS affects both the central and smaller peripheral bile ducts. CS combines cystic biliary dilatation (congenital intrahepatic ductal dilatation) and the features of congenital hepatic fibrosis, whereas CD is characterised solely by biliary dilatation. The origin of CD is unclear: it is thought to be usually nonhereditary, and it is rarely transmitted in an autosomal dominant mode. CS is transmitted in an autosomal recessive mode. While CD is assumed to result from a partial or complete interruption at an early phase of ductal plate remodelling, in CS, the abnormalities occur both at an early and at a late phase and involve peripheral bile ducts [8, 15]. Follow-up is mandatory for CS and CD due to the increased risk of cholangiocarcinoma [17]. In addition, the cysts and biliary tract can contain stones, resulting from the stagnation of bile.

Caroli disease


The lack of periportal biliary epithelium regression during embryogenesis creates the aneurysmal dilatation of the large intra-hepatic bile ducts [8, 15]. The liver parenchyma is normal. Frequent symptoms include abdominal pain, jaundice, and/or cholangitis.


The biliary tract is abnormal and there are focal dilated bile ducts, without stenosis (Fig. 10). The cystic dilatations are connected to the biliary tract and have thin walls with a “central dot sign,” corresponding to a residual portal vein and arterial branch [15]. The Doppler or contrast-enhanced CT/MRI images confirm its vascular origin [10].

Fig. 10
figure 10

Caroli disease in a 24-year-old male. a Axial magnetic resonance imaging in T2 and (b) in T1 on portal venous phase show both fusiform (arrows) and connected round (arrowheads) dilatations, better depicted on magnetic resonance cholangiopancreatography images (c). There is no associated sign of fibrosis

MRCP is the modality of choice for assessing these lesions. Cystic hepatic lesions communicate with the biliary tract (Fig. 10). The use of hepatobiliary MRI contrast agents can be useful to confirm the communication between the biliary tracts and cysts [15]. There is no liver atrophy (Fig. 10).

Caroli syndrome


This syndrome combines bile duct dilatations and congenital hepatic fibrosis. CS could be associated with the autosomal recessive polycystic kidney disease (PKHD1 mutation) [18]. The symptoms are due to the consequences of liver fibrosis. Follow-up is required not only to prevent the complications induced by hepatic fibrosis but also because of the increased risk of cholangiocarcinoma (about 7%) [17].


The features are similar to those of CD, with cysts communicating with the dilated bile ducts, and with the specific “central dot sign” (Fig. 11). They are usually smaller in CS than in CD (< 3 cm), with diffuse fusiform dilatation of the biliary tract [10].

Fig. 11
figure 11

Caroli syndrome in a 7-year-old female, at ultrasonography. Several round anechoic cysts (stars) with thin wall, increased through-transmission, connected to the dilated fusiform biliary tract (arrows), some of which show the highly specific “central dot sign” (arrowhead)

The associated hepatic fibrosis may lead to specific dysmorphia (hypertrophy of the left and caudate lobes, normal size or hypertrophy of segment IV and hypotrophy of the right lobe [19]) and to features of portal hypertension (portosystemic collateral vessels, splenomegaly and ascites) (Fig. 12).

Fig. 12
figure 12

Caroli syndrome in a 53-year-old female. a Axial magnetic resonance imaging on portal venous phase shows peripheric fusiform dilated bile duct, hyperintense on axial T2-weighted magnetic resonance imaging (b), with the specific “central dot sign” (arrows). Note the presence of spleno-renal shunts due to portal hypertension

Polycystic liver disease


Polycystic liver disease (PLD) may involve the liver only (autosomal dominant polycystic liver disease (ADPLD): ≈ 1:100,000), or the liver and the kidney, in a dominant (autosomal dominant polycystic kidney disease (ADPKD): ≈ 1:600–1,000) or recessive form (autosomal recessive polycystic kidney disease (ARPKD)) ≈ 1:20,000) [20]. The number of cysts required for diagnosis has not been clearly defined. The international PLD registry steering committee suggests that at least 10 simple hepatic cysts should be present for a diagnosis to be made [21]. As with SHCs, complications include organ compression (including biliary and hepatic vessels), haemorrhage, infection (Fig. 13) or rupture. The detection of an infected cyst among multiple ones might be difficult, but 18-Fluorine-fluorodeoxyglucose positron emission tomography (18-F-FDG PET) imaging may provide helpful guidance (Fig. 14).

Fig. 13
figure 13

Infected simple hepatic cysts in a 77-year-old male with autosomal dominant polycystic liver disease. a Axial non-enhanced computed tomography shows two cysts under pressure (arrow), slightly more attenuating than the non-infected cysts (arrowhead); b with a thick enhanced wall on the portal venous phase (arrowhead)

Fig. 14
figure 14

Infected cyst in a 65-year-old male patient with autosomal dominant polycystic liver disease. a Axial non-enhanced computed tomography depicts one more attenuating cyst among multiple simple cysts (cross); b 18-F-FDG PET imaging shows the increased metabolism of that cyst (SUV at 5,1)


Cysts, which are similar to SHCs, are spread diffusely throughout the liver (Fig. 15). They may coalesce then showing a linear calcification between them. They frequently lead to hepatomegaly and to vascular compression with venous collaterals [22].

Fig. 15
figure 15

Autosomal dominant polycystic kidney disease in a 38-year-old male patient. a Axial computed tomography on portal venous phase and b axial T2-weighted magnetic resonance imaging show several simple hepatic cysts and also numerous kidney cysts (arrows), with fluid signal (hypodense/hyperintense on T2)

Other cystic lesions

Peribiliary cyst


Peribiliary cysts, which are small serous cysts caused by obstructed extramural hilum peribiliary glands, must not be confused with biliary dilatations. The aetiopathogenesis of these cysts and their exact prevalence are unknown. They are mostly found in cirrhotic liver (50% in autopsy studies [23]), in ADPKD or ADPLD [24] and can be solitary (10%). They can sometimes cause compression and cholangitis. A classification of the cysts has been proposed according to their location: type I including intrahepatic biliary tract, type II extrahepatic biliary tract and type III intrahepatic and extrahepatic biliary tract (25).


Peribiliary cysts are characterised by multiple, usually small (from 1 to 55 mm [24]), simple cystic lesions, appearing as a “string of pearls” around the hilar portal veins (Fig. 16). They are predominantly located in the left lobe due to the preponderance of the peribiliary gland [10]. While they do not communicate with the biliary tract, they can communicate with one another, thereby mimicking biliary dilatations. MRCP is helpful to differentiate them from biliary dilatations (Fig. 16) and hepatobiliary MRI contrast agent can be used to prove the absence of biliary communication [10]. On rare occasions, peribiliary cysts can be confused with dilated lymphatic vessels [25].

Fig. 16
figure 16

Peribiliary cyst in a 69-year-old cirrhotic male. a Ultrasonography shows multiple periportal (arrowhead) cysts (arrows). b The portal vessels are clearly visible (arrowhead) on axial portal venous phase magnetic resonance imaging, showing the periportal location of the cysts. c and d Axial T2-weighted magnetic resonance imaging and magnetic resonance cholangiopancreatography images show multiple small cysts along thin, non-dilated bile ducts

Hepatic lymphatic malformation


Hepatic lymphatic malformations (HLM) are extremely rare (8 cases reported in the literature up to 2010 [26]). They consist of benign cystic dilatations of the liver’s lymphatic spaces, commonly associated with systemic lymphangiomatosis [6, 27]. These cysts are lined with endothelial cells and filled with lymph [27]. Three subtypes of HLM are described in the literature: capillary (super-microcystic), cavernous (microcystic), or cystic (macrocystic) [6, 27]. Through immunohistochemistry, D2-40 has been reported to be a highly specific antibody for the identification of the lymphatic endothelium when making a diagnosis during histological analysis [


They can be unilocular, but are more often multilocular, with septa and wall, which may enhance inconsistently. Confusion can occur with cystadenomas, cystadenocarcinomas or sclerosing haemangiomas [26, 29], but MRI can be usefully relied upon to avoid such a likelihood. The hepatic lymphatic malformations produce varying signals in T1- and T2-weighted sequences, depending on the quantity of fat and fluid components [30]. Lympho-MR sequences can show dilated lymph duct surrounding the lesion, thereby supporting the diagnosis of HLM [25, 28]. Finally, hepatic lymphatic malformations can spontaneously disappear (Fig. 17).

Fig. 17
figure 17

Spontaneous disappearance of a cystic lesion in a 5-year-old boy between 2017 and 2018, which led to the diagnosis of this lesion as a most likely liver lymphatic malformation. a Ultrasonography shows biloculated homogeneous cyst (arrow), which vanished one year later (star). It displayed fluid signal (arrows) on axial T2-weighted (b) and T1-weighted magnetic resonance imaging in 2017 (c). The main differential diagnosis of this lesion would be two fused simple hepatic cysts or mesenchymal hamartoma

Ciliated hepatic foregut duplication cyst


Ciliated hepatic foregut duplication cyst (CHFC) is a very rare (about 100 cases reported in the literature up to 2012 [31]) and usually incidental finding. It seems to be caused by a congenital malformation from the embryonic foregut [31]. It comprises four layers: an inner pseudo-stratified columnar epithelial lining, a subepithelial loose connective tissue, smooth muscle and a fibrous capsule [32]. Abdominal discomfort may be due to its subcapsular localisation [33].

The diagnosis can only be made by histology or through fine needle aspiration showing ciliated pseudostratified tall columnar epithelial cells suspended in a mucoid background with immunohistochemical stains [34]. Complete surgical excision is recommended [32] due to the risk of malignancy, especially if the cyst is larger than 5 cm [35, 36].


A small (< 4 cm) solitary subcapsular cyst in segment IV is very suggestive of CHFC. However, it has also been described in segment V or VIII [32, 33, 36]. Cysts are non-enhancing, without septa, partition or internal nodule.

Its contents are usually fatty or protein-rich, which may lead to the creation of a fluid–fluid layer [36]. On US, CHFC are hypoechoic, but usually not completely anechoic; on CT, they can be spontaneously hyperattenuating. On MRI, cysts are hyperintense on T2-weighted images, but the signal intensity is nonetheless not as high as that of simple hepatic cysts. On T1 images, the signal is usually spontaneously hyperintense. CHFCs do not demonstrate any contrast enhancement (Fig. 18) [37].

Fig. 18
figure 18

Ciliated hepatic foregut duplication cyst in a 15-year-old male. a Axial non-enhanced computed tomography shows a subcapsular nodule of the fourth segment with spontaneous attenuation value of around 50 Hounsfield Units. b On axial T1-weighted magnetic resonance imaging, it is spontaneously hyperintense. c It displays a high level of hyperintensity on axial T2-weighted magnetic resonance imaging. d Axial T1-weighted magnetic resonance imaging on portal venous phase shows neither contrast enhancement nor wall thickening

However, classical signs can be missed when the component of the cyst varies.

The differential diagnosis includes: haemorrhagic cyst, mucinous cystic neoplasm of the liver, metastasis of melanoma, dysplastic nodule (on cirrhosis liver), epidermoid and endometrial cyst. Some imaging patterns can help to accurately identify the different lesions. The haemorrhagic cyst is frequently larger, more heterogeneous and may show a peripheral hypointense T2 wall. The mucinous cystic neoplasm may show enhanced inner septa and a thick enhanced wall. The metastases of melanoma are most of the time less hyperintense on T2 and may show a slight enhancement. The dysplastic nodule is not hyperintense on T2. The epidermoid cyst is very rare and may be differentiated by fine needle aspiration. The endometrial cyst usually has sub-capsular topography.

Cystic tumours

Mucinous cystic neoplasm of the liver


Mucinous cystic neoplasms of the liver (MCN-L), previously known as biliary cystadenoma and cystadenocarcinoma, are rare cystic neoplasms (3–5% of hepatic cysts [9]) without biliary communication. MCN-L are composed of cuboidal to columnar epithelial cells, which variably produce mucin and which are associated with ovarian-type subepithelial stroma. They are subdivided into non-invasive and invasive types [38] and frequently occur in women. The diagnosis can be hinted at by the intralesional assay of specific tumour markers (TAG-72) [39].

Treatment requires surgery, since imaging cannot differentiate non-invasive from invasive types with certainty [9].


They are frequently large (1.5–35 cm) solitary multilocular cystic lesions, mostly located close to the hepatic hilum in segment IV, with well-circumscribed irregular margins and septations. Internal septa can be calcified [3]. Septations arising from the internal cyst wall without external indentation seem to be a specific sign that can be relied upon to differentiate MCN-L from SHC [7].

On US, they appear as large unilocular anechoic lesions, with thickened and irregular walls and internal septations [40]. Contrast-enhanced ultrasonography (CEUS) can confirm the enhancement of inner septa.

On CT, they appear as a solitary hypoattenuating lesion with septations, a thick wall, rarely with calcification [40]. The attenuation of the cyst varies, depending on the nature of the component.

On MRI, the signal intensity of the lesion may vary depending on the fluid content within each stall (e.g. protein rich), which is very specific [40]. A fluid–fluid level can be seen when there is haemorrhagic content. The capsule and the septa are enhanced with contrast administration (Fig. 19).

Fig. 19
figure 19

Typical non-invasive mucinous cystic neoplasm of the liver in a 59-year-old female. a Axial T2-weighted magnetic resonance imaging shows a solitary hyperintense cystic lesion, with hypointense septa (arrows). b Axial T1-weighted magnetic resonance imaging on portal venous phase depicts the enhancement of the capsule and septa (arrows)

Haemorrhagic fluid, solid mural nodule and calcification are most commonly associated with invasive lesions, mural nodules in particular being highly indicative of malignancy [4] (Fig. 20).

Fig. 20
figure 20

Invasive mucinous cystic neoplasm of the liver in a 50-year-old female. a Axial non-enhanced computed tomography shows a hypoattenuating lesion with a thick heterogeneous enhancing wall on portal venous phase (b), better seen on T1-weighted magnetic resonance imaging on portal venous phase (d) (arrows). Note the presence of cystic portions on axial T2-weighted sequence (c), in very intense hypersignal T2 (arrows)

It is difficult to carry out a differential diagnosis with mucinous metastases. Of course, the existence of older imaging is crucial, and the context and history of primary mucinous tumour are important elements to consider. The appearance and evolution under treatment are part of the diagnosis in this case. The presence of septa and mural nodule is atypical for mucinous metastases.

MCN should not be confused with an abscess. Unlike the abscess, the solid part of the lesion and the parietal thickening are asymmetric, with thin-walled and thickened parts. The fluid content of the cystic portion is pure fluid (frank hyperintensity on T2-weighted MRI), and no peripheral oedema is observed (hypoattenuated on CT, hyperintense on MRI).

Intraductal papillary neoplasm of the bile duct


Intraductal papillary neoplasm of the bile duct (IPNB) is a rare premalignant neoplasm of the bile duct (10% of all bile duct tumours [41]). However, 40% can contain malignant component [41] and the risk of malignant transformation is high. Lesions must be treated by surgical resection whenever possible [41,42,43].


The appearance of the lesions depends on the quantity of mucin produced by the tumours [44]. They mainly appear as an intraluminal cystic mass within the bile duct, with upstream duct dilatation (Fig. 21). If there is an increase in the production of mucin, lesions can appear only as focal or diffuse bile duct dilatations, without any visible solid part. The aneurysmal dilatation of a branch of the biliary tree is considered a characteristic sign of IPNB by some authors [45]. An obvious intracystic solid mass is suggestive of a malignant transformation [44]. An intra-luminal mass may appear hypo- or hyperechoic on US, and highly enhanced on CEUS, CT and MRI during the arterial phase (Fig. 21). CEUS is very sensitive for the detection of cystic walls or nodule enhancement [42]. In contrast to intraductal cholangiocarcinoma, enhancement does not increase in the portal and delayed phases [44]. Diffusion may be restricted, but it is not indistinguishable from that of cholangiocarcinoma.

Fig. 21
figure 21

Intraductal papillary neoplasm of the bile duct in a 67-year-old female. a Axial T2-weighted magnetic resonance imaging displays intraductal heterogeneous cystic and tissular mass (star) with dilated bile duct in contact (arrows). The cystic part of the mass is better seen at magnetic resonance cholangiopancreatography (b), and so are the upstream biliary dilatation (arrows) and the connection to the biliary tree (arrowhead). c and d Axial T1-weighted non-enhanced magnetic resonance imaging on arterial phase shows a highly enhanced tissular part

Secondary cystic lesion: cystic metastasis


Cystic metastases occur less frequently than solid metastases and purely cystic metastatic tumours without prior treatment are extremely rare. The cystic part of the metastases can be due to spontaneous necrosis, especially in the case of hyperenhancing metastases (neuroendocrine tumours, malignant melanomas, sarcomas or gastrointestinal stromal tumours (GIST)), or it can arise secondary to a systemic or locoregional treatment [3]. There are exceptional cases of cystic liver metastases from squamous cell carcinoma [46]. Mucin production (mucinous colorectal or ovarian adenocarcinoma) can also lead to cystic features.


They can be multilocular or unilocular, and present thick walls, irregular contours or mural nodules (Figs. 22, 23, 24, 25). Irregular thick septa are possible (Fig. 25). Since the fluid component results from mucin, necrosis or haemorrhage [3], the attenuation on CT and the signal on MRI are different from pure fluid. US may be useful to distinguish truly fluid cystic masses from cystic metastases, especially when they are small. CEUS can reveal fine peripheral arterial enhancement with early washout (Fig. 22). The clinical setting has to be considered.

Fig. 22
figure 22

Cystic metastasis from malignant melanoma in a 72-year-old female. a, b Axial computed tomography on arterial and portal venous phases shows unique hypoattenuating (20 Hounsfield Units) nodule of the right liver lobe, too small to be characterised. c Contrast-enhanced ultrasonography displays an enhanced wall as a “rim” (arrows)

Fig. 23
figure 23

Metastatic pancreatic neuroendocrine tumour in a 60-year-old male. a Axial computed tomography on portal venous phase shows a lobulated hypodense cystic nodule in segment V with enhanced mural nodule and septa (arrow), very hyperintense on T2-weighted magnetic resonance imaging (b). A second cystic subcapsular nodule is visible in segment VI

Fig. 24
figure 24

Pure cystic metastasis of a neuroendocrine tumour in a 69-year-old female. The hyperintensity on axial T2-weighted magnetic resonance imaging (a) is marked and there is no enhancement on arterial (arrow) or portal venous (arrow-head) phase (b, c)

Fig. 25
figure 25

Cystic metastasis of a mucinous tumour of the rectum in a 72-year-old male. The hyperintensity on axial T2-weighted magnetic resonance imaging a is marked but the multiple tiny septa (arrows) incompletely enhanced on portal venous phase (b) are sufficient to reach a conclusive diagnosis in this the context

Infectious cystic lesions

Pyogenic abscess


Frequent organisms of pyogenic abscesses are Escherichia coli, Klebsiella pneumoniae, Enterococcus, and Streptococcus [47]. Hyper-virulent strains of Klebsiella pneumoniae have been responsible for severe emerging diseases for the past two decades, particularly in Southeast Asia. Some of them are responsible for bacteremia combined with multiple abscesses (monomicrobial liver abscesses, endophthalmitis, brain abscesses) [48].

The differential diagnosis of pyogenic abscess is the amoebaean abscess.


Abscesses are rarely purely cystic and their appearance varies according to the pathologic stage. Before they turn into cystic abscesses, they display a pre-suppurative phase. Then, they appear as multiple cystic nodules (honeycomb pattern) which coalesce in a unique large irregularly shaped cystic cavity (cluster sign), surrounded by hypoattenuating inflammatory parenchyma (Fig. 26). The cluster sign is a feature indicative of pyogenic abscess [47]. The cystic central part appears on US as a large heterogeneous cystic mass, with mixed anechoic, hypoechoic and hyperechoic parts (Fig. 27). On CT and MRI, a rim and septa enhancement has been reported and the “double target” characteristic sign may be observed. This sign is a hypoattenuating central area of pus surrounded by an inner hyperattenuating ring (granulation tissue) and an outer hypoattenuating zone (inflammatory oedema) [3]. Gas may be present (Fig. 27). The central restriction of diffusion due to pus may be seen in larger abscesses.

Fig. 26
figure 26

Escherichia Coli abscess in an 89-year-old male. Axial computed tomography on portal venous phase shows three small hypoattenuating areas (arrows) forming the “cluster sign” and a large central hypoattenuating cavity (star)

Fig. 27
figure 27

Hepatic pyogenic abscesses in a 49-year-old male. a Ultrasonography shows a large heterogeneous hypoechoic lesion, with anechoic parts (star) and increased through transmission (arrows) confirming its cystic nature. b and c Axial computed tomography on portal venous phase displays multiple abscesses appearing as cystic masses, with a specific sign: the double target (arrows). Note the bubble of gas in one of them (arrow-head)

The appearance of abscesses can vary due to their pathogenesis: while cholangitic abscesses are mostly multiple small cystic nodules, abscesses by hematogenous dissemination are mostly larger and less numerous, and abscesses by contiguous spread are commonly solitary [49].

The thrombotic occlusion of the portal vein or of its branches, or the hepatic veins, is an additional feature supporting the diagnosis of pyogenic abscess [50].

Hydatid cyst


Hydatid cysts are caused by Echinococcus granulosis infection [3]. They consist of three layers: the outer pericyst, which corresponds to compressed and fibrosed liver tissue; the endocyst, an inner germinal layer; and the ectocyst, a thin, translucent interleaved membrane [51]. The cysts are mainly asymptomatic, but they can become complicated (biliary fistula, compression, rupture) (Fig. 28) [51].

Fig. 28
figure 28

Complicated hydatid cyst in a 50-year-old female. Imaging displays a cyst very close to the biliary tract with lobulated margins, showing a loss of intralesional pressure, most probably resulting from a complication of the biliary connection (not found on magnetic resonance cholangiopancreatography). a Axial T2-weighted magnetic resonance imaging. b Coronal 3D magnetic resonance cholangiopancreatography. c and d Axial T1-fat-sat-weighted imaging without and with contrast on portal venous phase


Their characteristic appearance varies, depending on the stage of the disease. On US, both the World Health Organization (WHO) and the Gharbi classification systems are used.

The WHO classification system contains seven categories, which depend on the stage of the disease. The first category is called cystic lesion (CL). These are unilocular anechoic lesions, which appear as simple hepatic cysts. CE1 (cystic echinococcosis 1) corresponds to an active stage: it appears as a uniform anechoic cyst with internal echoes (“hydatid sand”) on US, which may only be seen after patient repositioning. A peripheral hypointense capsule is visible on MRI. CE2 (active stage) (Fig. 29) is as a well-defined multicystic mass with septa. Half of the cases demonstrate calcification of the cyst wall [51, 52], which can be better seen on CT. It displays a multivesicular “honeycomb” appearance due to daughter cysts surrounding a larger “mother” cyst. On CT, the attenuation of the mother cyst is usually higher than that of the daughter cysts due to debris (hydatid sand and detached cysts wall); the signal intensity of the mother cyst is, respectively, higher and lower on T1- and T2-weighted MRI (Fig. 29). T2-weighted MRI sequences are more sensitive than CT to detect and characterise the cystic mass as a typical wheel-spoke pattern (Fig. 29). T2 images show septa and low signal intensity due to the presence of calcifications and to the fibrotic component. They have a different signal on T1-weighed images due to the cyst fluid, which varies according to the amount of proteinaceous debris [3]. Diffusion is not restricted [52]. CE3 is a transitional stage. CE3A is a unique cyst with detached laminated membranes described as the “water lily sign”[5153]. CE3B shows daughter cysts within a solid matrix. CE4 corresponds to an inactive stage. There are no more daughter cysts. It produces both hypoechoic and hyperechoic signal, whose pattern resembles a ball of wool [53]. (inactive/degenerative stage), is partially or completely calcified.

Fig. 29
figure 29

cyst echinococcosis 2, in a 50-year-old male. a Axial non-enhanced computed tomography shows a heterogeneous mass with a cystic part (arrow) and calcification of the wall (arrowhead). b On axial computed tomography on portal venous phase no enhancement of the cystic component is observed. c The cystic part and the differentiation between the daughter (arrow) and the mother (star) cysts are better evaluated on axial T2-weighted magnetic resonance imaging. d Coronal 3D magnetic resonance cholangiopancreatography excludes biliary fistula from the possible diagnosis

Hepatic alveolar echinococcosis


This is a rare parasitic infection due to Echinococcus multilocularis. In contrast to the hydatid cyst, a fibrous capsule does not usually demarcate the outer margin. It is a chronic and latent disease, which is usually detected incidentally [52]. When it is symptomatic, it causes compression symptoms. The treatment is medical and surgical. The prognosis is usually poor, sometimes leading to liver transplantation.


Hepatic alveolar echinococcosis (HEA) lesions present irregular margins, with a mixed component of solid and cystic parts. Calcifications frequently occur. The lack of enhancement is very helpful to reach a diagnosis.

On US, HEA lesions appear as a large heterogeneous mass, with areas of hyper- and hypoechogenicity (Fig. 30), hyperechoic spots (corresponding to calcifications), and a central cystic anechoic cavity (due to necrosis) [52]. More rarely they appear as multiple hyperechoic nodules with calcification and a cystic part. CT is helpful to identify the calcification. The lesions, which are hypoattenuating, heterogeneous, with irregular margins and calcification, may attract the surrounding parenchyma and distort the hepatic capsule. Usually, no contrast enhancement is observed. In the late phase, the fibrotic component may display mild enhancement. The use of MRI prior to surgery is crucial, because it helps to assess the diagnosis, demonstrating the multivesicular structure of the lesion, and allowing vascular or biliary tree involvement to be assessed [52]. The signal intensity of the cystic part ranges from low to intermediate on T1-weighted images and is high on T2-weighted images; the fibrous part demonstrates low signal intensity both on the T1- and the T2-weighted images (Fig. 30).

Fig. 30
figure 30

Hepatic alveolar echinococcosis in a 40-year-old male. a Ultrasonography shows multiple round hyperechoic nodules (arrows) with cystic anechoic parts (arrowhead). b On Axial T2-weighted magnetic resonance imaging, the lesions appear as multivesicular cystic masses (arrows) with a fibrous component (arrowhead). c and d On axial non-enhanced T1-fat-sat-weighted magnetic resonance imaging, the fibrous part is enhancing on late phase (arrow)

Therapeutic efficacy in HAE is essentially evaluated on the basis of repeated 18-F-FDG PET CT [54].


Cystic liver lesions encompass a wide and varied spectrum of features. To characterise them, a particular attention should be paid to wall thickness, to the presence of enhanced septa or solid components, to the fluid signal on MRI and to the clinical context. Since cystic liver lesions may be malignant, all non-SHCs should be investigated to make a conclusive diagnosis.



18-Fluorine-fluorodeoxyglucose positron emission tomography


Autosomal dominant polycystic kidney disease


Autosomal dominant polycystic liver disease


Bile duct hamartomas


Carbohydrate antigen 19-9


Caroli disease


Cystic echinococcosis


Cystic echinococcosis 1


Cystic echinococcosis 2


Cystic echinococcosis 3


Cystic echinococcosis 4


Cystic echinococcosis 5


Carcinoembryonic antigen


Contrast-enhanced ultrasonography


Congenital hepatic fibrosis


Ciliated hepatic foregut duplication cysts


Cystic lesion


Caroli syndrome


Computed tomography


Gastrointestinal stromal tumour


Hepatic cysts


Hepatic alveolar echinococcosis


Hepatic lymphatic malformation


Hounsfield units


Intraductal papillary neoplasms of the bile duct


Mucinous cystic neoplasms of the liver


Magnetic resonance cholangiopancreatography


Magnetic resonance imaging


Polycystic liver disease


Simple hepatic cysts


Tumour-associated glycoprotein 72




World health organization


  1. Kaltenbach TE-M, Engler P, Kratzer W et al (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol (NY) 41(1):25–32

    Article  Google Scholar 

  2. Mortelé KJ, Ros PR (2001) Cystic focal liver lesions in the adult: differential CT and MR imaging features. Radiographics 21(4):895–910

    PubMed  Article  Google Scholar 

  3. Qian LJ, Zhu J, Zhuang ZG, Xia Q, Liu Q, Xu JR (2013) Spectrum of multilocular cystic hepatic lesions: CT and MR imaging findings with pathologic correlation. Radiographics 33(5):1419–1433

    PubMed  Article  Google Scholar 

  4. Borhani AA, Wiant A, Heller MT (2014) Cystic hepatic lesions: a review and an algorithmic approach. AJR Am J Roentgenol 203(6):1192–1204

    PubMed  Article  Google Scholar 

  5. Singh Y, Winick AB, Tabbara SO (1997) Multiloculated cystic liver lesions: radiologic-pathologic differential diagnosis. Radiographics 17(1):219–224

    CAS  PubMed  Article  Google Scholar 

  6. Gonidec S, Guibal A, Pilleul F (2011) Lymphangiome hépatique isolé de l’adulte: aspects IRM. J Radiol 92(7–8):729–731

    CAS  PubMed  Article  Google Scholar 

  7. Kovacs MD, Sheafor DH, Burchett PF, Picard MM, Hardie AD (2018) Differentiating biliary cystadenomas from benign hepatic cysts: Preliminary analysis of new predictive imaging features. Clin Imaging 49:44–47

    PubMed  Article  Google Scholar 

  8. Desmet VJ (1998) Pathogenesis of ductal plate abnormalities. Mayo Clin Proc 73(1):80–89

    CAS  PubMed  Article  Google Scholar 

  9. Mavilia MG, Pakala T, Molina M, Wu GY (2018) Differentiating Cystic liver lesions: a review of imaging modalities, diagnosis and management. J Clin Transl Hepatol 6(2):1–9

    Article  Google Scholar 

  10. Vilgrain V, Régent D (2010) Imagerie de l’abdomen. Lavoisier. (Imagerie Médicale)

  11. Kohno S, Arizono S, Isoda H, Yoshizawa A, Togashi K (2019) Imaging findings of hemorrhagic hepatic cysts with enhancing mural nodules. Abdom Radiol (NY) 44(4):1205–1212

    Article  Google Scholar 

  12. Torbenson MS (2019) Hamartomas and malformations of the liver. Semin Diagn Pathol 36(1):39–47

    PubMed  Article  Google Scholar 

  13. Pech L, Favelier S, Falcoz MT, Loffroy R, Krause D, Cercueil JP (2016) Imaging of Von Meyenburg complexes. Diagn Interv Imaging 97(4):401–409

    CAS  PubMed  Article  Google Scholar 

  14. Nasr D, Bidot M-L, Roche M et al (2006) Maladie des complexes de von Meyenburg (micro-hamartomes biliaires) découverte lors d’une chirurgie laparoscopique: à propos de deux observations. Ann Chir 131(8):468–470

    CAS  PubMed  Article  Google Scholar 

  15. Mamone G, Carollo V, Cortis K, Aquilina S, Liotta R, Miraglia R (2019) Magnetic resonance imaging of fibropolycystic liver disease: the spectrum of ductal plate malformations. Abdom Radiol (NY) 44(6):2156–2171

    Article  Google Scholar 

  16. Correia PC, Morgado B (2017) Caroli’s disease as a cause of chronic epigastric abdominal pain: two case reports and a brief review of the literature. Cureus.

    Article  Google Scholar 

  17. Fahrner R, Dennler SG, Inderbitzin D (2020) Risk of malignancy in caroli disease and syndrome: a systematic review. World J Gastroenterol 26(31):4718–4728

    PubMed  PubMed Central  Article  Google Scholar 

  18. Alsomali MI, Yearsley MM, Levin DM, Chen W (2020) Diagnosis of congenital hepatic fibrosis in adulthood. Am J Clin Pathol 153(1):119–125

    PubMed  Article  Google Scholar 

  19. Mamone G, Cortis K, Sarah A, Caruso S, Miraglia R (2018) Hepatic morphology abnormalities: beyond cirrhosis. Abdom Radiol (NY) 43(7):1612–1626

    Article  Google Scholar 

  20. Santos-Laso A, Izquierdo-Sánchez L, Lee-Law P et al (2017) New advances in polycystic liver diseases. Semin Liver Dis 37(01):045–055

    CAS  Article  Google Scholar 

  21. van Aerts RMM, van de Laarschot LFM, Banales JM, Drenth JPH (2018) Clinical management of polycystic liver disease. J Hepatol 68(4):827–837

    PubMed  Article  Google Scholar 

  22. Barbier L, Ronot M, Aussilhou B et al (2018) Polycystic liver disease: hepatic venous outflow obstruction lesions of the noncystic parenchyma have major consequences. Hepatology 68(2):652–662

    PubMed  Article  Google Scholar 

  23. Lim J, Nissen NN, McPhaul C, Annamalai A, Klein AS, Sundaram V (2016) Peribiliary hepatic cysts presenting as hilar cholangiocarcinoma in a patient with end-stage liver disease. J Surg Case Rep.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Bazerbachi F, Haffar S, Sugihara T et al (2018) Peribiliary cysts: a systematic review and proposal of a classification framework. BMJ Open Gastroenterol 5(1):e000204

    PubMed  PubMed Central  Article  Google Scholar 

  25. Arrivé L, Monnier-Cholley L, Cazzagon N, Wendum D, Chambenois E, El Mouhadi S (2019) Non-contrast MR lymphography of the lymphatic system of the liver. Eur Radiol 29(11):5879–5888

    PubMed  Article  Google Scholar 

  26. Matsumoto T, Ojima H, Akishima-Fukasawa Y et al (2010) Solitary hepatic lymphangioma: report of a case. Surg Today 40(9):883–889

    PubMed  Article  Google Scholar 

  27. Lee HH, Lee SY (2016) Case report of solitary giant hepatic lymphangioma. Korean J Hepatobiliary Pancreat Surg 20(2):71

    PubMed  PubMed Central  Article  Google Scholar 

  28. Nakano T, Hara Y, Shirokawa M et al (2015) Hemorrhagic giant cystic lymphangioma of the liver in an adult female. J Surg Case Rep.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Sugo H, Sekine Y, Miyano S et al (2018) Hepatic sclerosing hemangioma with predominance of the sclerosed area mimicking a biliary cystadenocarcinoma. Case Rep Hepatol 4(2018):1–6

    Google Scholar 

  30. Stunell H, Ridgway PF, Torreggiani WC, Crotty P, Conlon KC (2009) Hepatic lymphangioma: a rare cause of abdominal pain in a 30-year-old female. Ir J Med Sci 178(1):93–96

    CAS  PubMed  Article  Google Scholar 

  31. Ambe C, Gonzalez-Cuyar L, Farooqui S, Hanna N, Cunningham SC (2012) Ciliated hepatic foregut cyst: 103 cases in the world literature. Open J Pathol 02(03):45–49

    Article  Google Scholar 

  32. Bishop KC, Perrino CM, Ruzinova MB, Brunt EM (2015) Ciliated hepatic foregut cyst: a report of 6 cases and a review of the English literature. Diagn Pathol.

    Article  PubMed  PubMed Central  Google Scholar 

  33. de la Serna S, García-Botella A, Fernández-Aceñero M-J, Esteban F, Diez-Valladares L-I (2016) Quiste ciliado hepático, diagnóstico diferencial de lesiones hepáticas del segmento iv. Cir Esp 94(9):545–547

    PubMed  Article  Google Scholar 

  34. Sharma S, Corn A, Kohli V, Wright HI, Sebastian A, Jabbour N (2008) Ciliated hepatic foregut cyst: an increasingly diagnosed condition. Dig Dis Sci 53(10):2818–2821

    PubMed  Article  Google Scholar 

  35. Wilson JM, Groeschl R, George B et al (2013) Ciliated hepatic cyst leading to squamous cell carcinoma of the liver – a case report and review of the literature. Int J Surg Case Rep 4(11):972–975

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. Ansari-Gilani K, Modaresi Esfeh J (2015) Ciliated hepatic foregut cyst: report of three cases and review of imaging features. Gastroenterol Rep.

    Article  Google Scholar 

  37. Boumoud M, Daghfous A, Maghrebi H et al (2015) Imaging features of ciliated hepatic foregut cyst. Diagn Interv Imaging 96(3):301–303

    CAS  PubMed  Article  Google Scholar 

  38. WHO Classification of Tumours Editorial Board (2019) Digestive system tumours 5th Edition. International agency for research on cancer

  39. Fuks D, Voitot H, Paradis V, Belghiti J, Vilgrain V, Farges O (2014) Intracystic concentrations of tumour markers for the diagnosis of cystic liver lesions: tumour markers for diagnosing cystic liver lesions. Br J Surg 101(4):408–416

    CAS  PubMed  Article  Google Scholar 

  40. Averbukh LD, Wu DC, Cho WC, Wu GY (2019) Biliary mucinous cystadenoma: a review of the literature. J Clin Transl Hepatol 7:1–5

    Article  Google Scholar 

  41. Tominaga K, Kamimura K, Sakamaki A, Terai S (2017) Intraductal papillary neoplasm of the bile duct: a rare liver tumor complicated by malignancy. Hepatology 66(5):1695–1697

    PubMed  Article  Google Scholar 

  42. Hasebe T, Sawada K, Hayashi H et al (2019) Long-term growth of intrahepatic papillary neoplasms: a case report. World J Gastroenterol 25(36):5569–5577

    PubMed  PubMed Central  Article  Google Scholar 

  43. Kunovsky L, Kala Z, Svaton R et al (2018) Mucinous cystic neoplasm of the liver or intraductal papillary mucinous neoplasm of the bile duct? a case report and a review of literature. Ann Hepatol 17(3):519–524

    PubMed  Article  Google Scholar 

  44. Chatterjee A, Lopes Vendrami C, Nikolaidis P et al (2019) Uncommon intraluminal tumors of the gallbladder and biliary tract: spectrum of imaging appearances. Radiographics 39(2):388–412

    PubMed  Article  Google Scholar 

  45. Lim JH, Yoon K-H, Kim SH et al (2004) Intraductal papillary mucinous tumor of the bile ducts. Radiographics 24(1):53–66

    PubMed  Article  Google Scholar 

  46. Liu Q, Wang J, Sun C, Xu J (2018) The diagnosis and management of rare cystic liver metastases from nasopharyngeal carcinoma: a case report. Medicine (Baltimore) 97(26):e11257

    Article  Google Scholar 

  47. Joshi G, Crawford KA, Hanna TN, Herr KD, Dahiya N, Menias CO (2018) US of right upper quadrant pain in the emergency department: diagnosing beyond gallbladder and biliary disease. Radiographics 38(3):766–793

    PubMed  Article  Google Scholar 

  48. Rossi G, Lafont E, Gasperini L et al (2016) Abcès hépatiques. Rev Médecine Interne 37(12):827–833

    CAS  Article  Google Scholar 

  49. Bächler P, Baladron MJ, Menias C et al (2016) Multimodality imaging of liver infections: differential diagnosis and potential pitfalls. Radiographics 36(4):1001–1023

    PubMed  Article  Google Scholar 

  50. Syed MA, Kim TK, Jang H-J (2007) Portal and hepatic vein thrombosis in liver abscess: CT findings. Eur J Radiol 61(3):513–519

    PubMed  Article  Google Scholar 

  51. Mortelé KJ, Segatto E, Ros PR (2004) The infected liver: radiologic-pathologic correlation. Radiographics 24(4):937–955

    PubMed  Article  Google Scholar 

  52. Kantarci M, Bayraktutan U, Karabulut N et al (2012) Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics 32(7):2053–2070

    PubMed  Article  Google Scholar 

  53. Mirabile E, Solomon N, Fields PJ, Macpherson CNL (2019) Progress towards international adoption of the World Health Organization ultrasound classification of cystic echinococcosis. Acta Trop 189:6–9

    CAS  PubMed  Article  Google Scholar 

  54. Azizi A, Blagosklonov O, Lounis A et al (2015) Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdom Imaging 40(1):56–63

    PubMed  Article  Google Scholar 

Download references


We thank all the radiology team of University Hospital of Angers, who participated in the collection of cases.


The authors declare that they have received no funding.

Author information

Authors and Affiliations



MC wrote the manuscript. AP and CA were major contributors in revising the manuscript. MR revised the manuscript. MC, AP and CA identified and collected most of the images. PB, JL, DK, MR and VL provided cases. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mégane Chenin.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chenin, M., Paisant, A., Lebigot, J. et al. Cystic liver lesions: a pictorial review. Insights Imaging 13, 116 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Hepatic
  • Cysts
  • Ultrasonography
  • Computed tomography
  • Magnetic resonance imaging